Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00229996 · ClinicalTrials.gov registry record · Phase 3
Medical Treatment of Endometriosis-Associated Pelvic Pain
A Phase 3 study of Endometriosis and Pelvic Pain, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 3
- Development phase
- 194
- Enrollment target
- 1
- Study location
NCT00229996: Completed Phase 3 study of Endometriosis and Pelvic Pain, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT00229996 is a Phase 3 study of Endometriosis and Pelvic Pain that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 194 participants, below the 260-participant average among 48 other Endometriosis trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00229996, a Phase 3 study of Endometriosis and Pelvic Pain, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 194 participants
- Enrollment target
- 1
- Study location
Study Summary
The Specific Aim of this project is to compare the efficacy and cost-effectiveness of continuous oral contraceptives versus leuprolide/norethindrone in the treatment of endometriosis-associated chronic pelvic pain. This comparison will be based on a randomized, double-blind, trial of women with chronic pelvic pain who have been diagnosed with endometriosis at the time of surgery within the last 3 years. We hypothesize that, over a 12-month period of postoperative treatment, the efficacy of oral contraceptives is no worse than leuprolide/norethindrone, and that treatment with oral contraceptives is more cost-effective.
Conditions Studied
Interventions
- DRUG Oral Contraceptive
- DRUG Depot-Leuprolide/Norethindrone
Study Locations (1)
Massachusetts
- Brigham and Womens Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2004-07 |
| Phase | Phase 3 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What the finished NCT00229996 record still lists
NCT00229996 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 260-participant average among 48 other Endometriosis trials with a reported enrollment target (25% lower).
The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Oral Contraceptive is the first listed.
NCT00229996 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00229996 about?
NCT00229996 is a clinical study titled "Medical Treatment of Endometriosis-Associated Pelvic Pain". The Specific Aim of this project is to compare the efficacy and cost-effectiveness of continuous oral contraceptives versus leuprolide/norethindrone in the treatment of endometriosis-associated chronic pelvic pain. This comparison will be based on a randomized, double-blind, trial of women with chro...
What is the current status of trial NCT00229996?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 194 participants. The study started on 2004-07.
What conditions does trial NCT00229996 study?
This clinical trial studies the following conditions: Endometriosis, Pelvic Pain.
What interventions are being tested in trial NCT00229996?
The interventions under investigation include: Oral Contraceptive (DRUG), Depot-Leuprolide/Norethindrone (DRUG).
Who is sponsoring clinical trial NCT00229996?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00229996 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00229996's enrollment target sits among peer trials
194 10th of 48 higher than 39 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
RECRUITING · Phase 3
-
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
RECRUITING · Phase 3
-
The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
RECRUITING · Phase 3
-
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
RECRUITING · Phase 3
-
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
ACTIVE NOT RECRUITING · Phase 3
-
SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia